Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Effects of early recombinant human growth hormone treatment in young Chinese children with Prader–Willi syndrome

Fig. 2

Changes in height SDS (A), weight SDS (B), and weight for height SDS (C) between the early treatment group (shaded) and later treatment group (blank) from baseline to 4 years old. Height-SDS, weight-SDS, and weight for height-SDS were adjusted for sex and age according to WHO child growth standards. Error bars represent means with 95% CI. #, P < 0.05, compared with the later treatment group

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172